Skip to main content
. 2018 Aug 24;9(66):32624–32641. doi: 10.18632/oncotarget.25976

Table 5. Validation of antibodies used for RPPA by western-blot (W-B) and ELISA.

Target antibody W-B (pattern of bands) ELISA (average concentration, n = 40) RPPA (average concentration, n = 40) Correlation coefficient between RPPA and ELISA (R,P)
MMP-9 MAB9111 S 232.22 ng/ml 24.92 ng/ml R = 0.936, P < 0.0001*
AF911 M 232.22 ng/ml 1485.69 ng/ml R = –0.71, P = 0.001
MAB936 M 232.22 ng/ml 862.44 ng/ml R = 0.582, P = 0.011
Acrp30 MAB10651 M 89.85 ng/ml 723.83 ng/ml R = 0.39, P = 0.401
BAM1065 M 89.85 ng/ml 2.64 ng/ml R = 0.504, P = 0.092
AF1065 S 89.85 ng/ml 3144.45 ng/ml R = 0.971, P < 0.0001*
hVEGF PB0276B M 0.42 ng/ml 382.37 ng/ml R = 0.346, P = 0.533
MAB293 M 0.42 ng/ml 0.47 ng/ml R = 0.691, P = 0.067
BAF293 M 0.42 ng/ml 1184.23 ng/ml R = –0.62, P = 0.054
ApoA S 114.07 ug/ml 1235.67 ug/ml R = 0.989, P < 0.0001*
ApoE S 54.97 ug/ml 20.59 ug/ml R = 0.942, P < 0.0001*
A2M S 707.94 ng/ml 4.17 ng/ml R = 0.746, P = 0.0002*
Clusterin S 117.83 58.22 R = 0.176, P = 0.278
CRP S 0.55 0.32 R = 0.769, P = 0.0003*

S: single band from western-blot; M: multiple bands from western-blot; P < 0.05 means statistically significant; *means good correlation of RPPA with ELISA.